全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2016 

血管内皮生长因子基因多态性与陕西汉族阿尔茨海默病的相关性研究
Association between single-nucleotide polymorphisms of vascular endothelial growth factor gene and Alzheimer’s disease in Shaanxi Han population

DOI: 10.7652/jdyxb201603012

Keywords: 阿尔茨海默病,血管内皮生长因子,单核苷酸多态性,陕西汉族
Alzheimer’s disease
,vascular endothelial growth factor,single nucleotide polymorphism,Shaanxi Han population

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 旨在探讨血管内皮生长因子(vascular endothelial growth factor, VEGF)基因8个单核苷酸多态性(single-nucleotide polymorphism, SNP)位点与陕西汉族阿尔茨海默病(Alzheimer disease, AD)的相关性。方法 选取陕西汉族AD患者214名(疾病组)及健康体检者(对照组)249名提取基因组DNA,采用基质辅助激光解吸电离飞行时间质谱技术对9个SNP的基因型进行分型,采用SPSS 16.0及Haploview 4.2软件统计分析各基因型、等位基因及单倍型频率在病例组及对照组中的差异。结果 VEGF基因rs3025039(3’非翻译区)基因型及等位基因频率分布在AD组及正常对照组差异有统计学意义(P<0.05)。AD组T等位基因频率显著高于正常对照组(P=0.008,OR=1.527, 95% CI=1.116~2.088)。连锁不平衡分析发现2个单倍型高度连锁(单倍型1:rs699947-rs1570360-rs2010963;单倍型2:rs3024997-rs3024998-rs3025006)(D’>0.9)。然而,其单倍型频率在AD组及正常对照组均无统计学差异(P>0.05)。结论 VEGF基因功能区rs3025039位点可能与AD有关,携带有rs3025039 T等位基因的个体可能更容易患AD。
ABSTRACT: Objective To evaluate the association between 8 single nucleotide polymorphisms (SNPs) of vascular endothelial growth factor (VEGF) gene and the risk of Alzheimer’s disease (AD) in Shaanxi Han population. Methods We examined the potential association between AD and 8 SNPs of VEGF gene using the MassARRAY system. The participants enrolled in this study included 214 patients with AD and 249 healthy controls from Shaanxi Han population. SPSS16.0 and Haploview 4.2 were employed to analyze differences in genotypes, alleles and haplotypes between the two groups. Results The results showed that rs3025039 (3’UTR) were significantly associated with AD (P<0.05). Greater frequency of rs3025039 T allele (P=0.008, OR=1.527, 95% CI=1.116-2.088) was found in AD subjects. Furthermore, strong linkage disequilibrium (LD) was observed in 2 locks (block1: rs699947-rs1570360-rs2010963; block 2: rs3024997-rs3024998-rs3025006) (D’>0.9). There were no significant haplotypes in block 1 and block 2 (P=0.034) found between the patients and controls. Conclusion These findings point to the role for VEGF gene polymorphisms (rs3025039) in AD of a Shaanxi Han population. Individuals with T allele of rs3025039 may be at a higher risk for AD

References

[1]  WANG Y, JIN K, MAO XO, et al. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration[J]. J Neurosci Res, 2007, 85(4):740-747.
[2]  MATEO I, LLORCA J, INFANTE J, et al. Low serum VEGF levels are associated with Alzheimer’s disease[J]. Acta Neurol Scand, 2007, 116(1):56-58.
[3]  THIRUMANGALAKUDI L, SAMANY PG, OWOSO A, et al. Angiogenic proteins are expressed by brain blood vessels in Alzheimer’s disease[J]. J Alzheimer’s Dis, 2006, 10(1):111-118.
[4]  NANA-SINKAM SP, CROCE CM. MicroRNAs as therapeutic targets in cancer[J]. Transl Res, 2011, 157(12):216-225.
[5]  LAFUENTE JV, ORTUZAR N, BENGOETXEA H, et al. Vascular endothelial growth factor and other angioglioneurins: key molecules in brain development and restoration[J]. Int Rev Neurobiol, 2012, 102, 317-346.
[6]  SUN Y, JIN K, XIE L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia[J]. J Clin Investig, 2003, 111(12): 1843-1852.
[7]  QIN W, JIA X, WANG F, et al. Elevated plasma angiogenesis factors in Alzheimer’s disease[J]. J Alzheimers Dis, 2015, 45(1):245-252.
[8]  QI M, HUANG X, ZHOU L, et al. Four polymorphisms of VEGF (+405C&gt;
[9]  G, -460T&gt; C, -2578C&gt; A, and -1154G&gt; A) in susceptibility to psoriasis: a meta-analysis[J]. DNA Cell Biol, 2014, 33(4):234-244.
[10]  LIU SY, ZENG FF, CHEN ZW, et al. Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer’s disease risk: a meta-analysis[J]. CNS Neurosci Ther, 2013, 19(7):469-476.
[11]  HE D, LU W, CHANG K, et al. Vascular endothelial growth factor polymorphisms and risk of Alzheimer’s disease: a meta-analysis[J]. Gene, 2013, 518(2):296-302.
[12]  欧陵斌,梁长香. 阿尔茨海默病的致病因素和临床用药研究[J]. 检验医学与临床, 2011, 8(2):251-252.
[13]  LA D, TORRE J. The vascular hypothesis of Alzheimer’s disease: bench to bedside and beyond[J]. Neurodegener Dis, 2010, 7(1-3):116-121.
[14]  ZLOKOVIC BV, GHISO J, MACKIC JB, et al. Blood-brain barrier transport of circulating Alzheimer’ s amyloid β[J]. Biochem Biophys Res Commun, 1993, 197(3): 1034-1040.
[15]  LAMBRECHTS D, CARMELIET P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease[J]. Biochim Biophys Acta Mol Basis Dis, 2006, 1762(11-12):1109-1121.
[16]  YABUSAKI N, YAMADA S, SHIMOYAMA Y, et al. A vascular endothelial growth factor gene polymorphism predicts malignant potential in intraductal papillary mucinous neoplasm[J]. Pancreas, 2015, 44(4):608-614.
[17]  MATEO I, LLORCA J, INFANTE J, et al. Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer’s disease[J]. Neurosci Lett, 2006, 401(1-2):171-173.
[18]  XU X, DU C, LI H, et al. Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis[J]. PLoS One, 2015, 10(4):e0123696.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133